Louise Vetter

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Recent clinical trials for Huntington's disease (HD) have been slowed by the inability to complete enrollment in a timely manner. We report a successful advocacy-based recruiting approach at Evergreen Neuroscience Institute, a new Huntington Study Group (HSG) investigative site that lacked an HD patient base. By partnering with community advocates and(More)
  • 1